Arbutus reports fourth quarter and year end 2024 financial results and provides corporate update

Claim construction hearing for pfizer/biontech mrna-lnp vaccine litigation occurred in december 2024; outcome pending

ABUS Ratings Summary

ABUS Quant Ranking